The store will not work correctly when cookies are disabled.
JavaScript 似乎在您的浏览器中禁用。
在我们的网站上获得最佳体验,请务必打开 Javascript 在您的浏览器。
340,000+ 科研产品
·
三重ISO认证
·
每个产品均提供COA和SDS
·
现货产品当日发货
Duligotuzumab (anti-EGFR&HER3)
级别和纯度:
无动物源 ?
无动物源(Animal Free)—— 不含动物源成分生产,降低污染风险。适用于避免动物源材料的生物制造和培养。
无载体 ?
无载体(Carrier Free)—— 不含添加的载体蛋白/稳定剂。当载体(如 BSA)会干扰偶联或敏感检测时使用。
重组 ?
重组(Recombinant)—— 通过重组表达生产,序列确定、批次稳定。适用于来源明确、无动物源的可重现蛋白。
ExactAb™ ?
ExactAb™ —— 阿拉丁强调精准和验证质量的抗体系列。适用于可靠、特异性经验证的抗体应用。
低内毒素 ?
低内毒素级 —— 内毒素降至受控低水平。适用于高内毒素会造成干扰的敏感生物工作。
无叠氮钠 ?
无叠氮(Azide Free)—— 不含叠氮化钠防腐剂。适用于叠氮有毒或有抑制作用的偶联、细胞工作或检测。
已验证 ?
已验证级 —— 发布前在特定应用中确认性能。当需要试剂按声称工作的书面保证时使用。
≥90%(SDS-PAGE&SEC-HPLC)
见COA
应用
Animal Model, ELISA, Flow Cytometry, Functional Assay
概述
Duligotuzumab (anti-EGFR&HER3) 是一种双特异性抗体,靶向 EGFR 和 HER3。
Duligotuzumab (anti-EGFR&HER3) is a bispecific antibody targeting to both EGFR and HER3.
规格
产品名称
Duligotuzumab (anti-EGFR&HER3)
别名
度戈妥珠单抗|杜利妥珠单抗(抗表皮生长因子受体和表皮生长因子受体3)|EGFR&ERBB3抗体|EGFR&ERBB3单克隆抗体|EGFR&ERBB3药靶抗体
英文别名
Avian erythroblastic leukemia viral (v erb b) oncogene homolog antibody|Cell growth inhibiting protein 40 antibody|Cell proliferation inducing protein 61 antibody|EGF R antibody|EGFR antibody|Epidermal growth factor receptor (avian erythroblastic leukemia viral (v erb b) oncogene homolog) antibody|Epidermal growth factor receptor (erythroblastic leukemia viral (v erb b) oncogene homolog avian) antibody|Epidermal growth factor receptor antibody|erb-b2 receptor tyrosine kinase 1 antibody|ERBB antibody|ERBB1 antibody|Errp antibody|HER1 antibody|mENA antibody|NISBD2 antibody|Oncogen ERBB antibody|PIG61 antibody|Proto-oncogene c-ErbB-1 antibody|Receptor tyrosine protein kinase ErbB 1 antibody|Receptor tyrosine-protein kinase ErbB-1 antibody|SA7 antibody|Species antigen 7 antibody|Urogastrone antibody|v-erb-b Avian erythroblastic leukemia viral oncogen homolog antibody|wa2 antibody|Wa5 antibody|c erbB 3 antibody|c erbB3 antibody|Erb b2 receptor tyrosine kinase 3 antibody|ErbB 3 antibody|ERBB3 antibody|ERBB3 protein antibody|erbB3 S antibody|Glial growth factor receptor antibody|HER 3 antibody|HER3 antibody|Human epidermal growth factor receptor 3 antibody|LCCS2 antibody|MDA BF 1 antibody|MGC88033 antibody|p180 ErbB3 antibody|p45 sErbB3 antibody|p85 sErbB3 antibody|proto-oncogene-like protein c ErbB 3 antibody|proto-oncogene-like protein c ErbB3 antibody|Proto-oncogene-like protein c-ErbB-3 antibody|Receptor tyrosine protein kinase erbB 3 antibody|Receptor tyrosine protein kinase erbB3 antibody|Receptor tyrosine-protein kinase erbB-3 antibody|Tyrosine kinase type cell surface receptor HER3 antibody|Tyrosine kinase-type cell surface receptor HER3 antibody|v erb b2 avian erythroblastic leukemia viral oncogene homolog 3 antibody|v erb b2 erythroblastic leukemia viral oncogene homolog 3 (avian) antibody|v erb b2 erythroblastic leukemia viral oncogene homolog 3 antibody|avian erythroblastic leukemia viral (v-erb-b) oncogene homolog|cell growth inhibiting protein 40|cell proliferation-inducing protein 61|EGF R|EGFR|epidermal growth factor receptor (avian erythroblastic leukemia viral (v-erb-b)oncogene homolog)|epidermal growth factor receptor|ErbB|ErbB1|HER1|HER-1|mENA|Proto-oncogene c-ErbB-1|Receptor tyrosine-protein kinase erbB-1|c-erbB3|ErbB3|ErbB-3|erbB3-S|HER3|HER3c-erbB-3|LCCS2|lethal congenital contracture syndrome 2|MDA-BF-1|p180-ErbB3|p45-sErbB3|p85-sErbB3|Proto-oncogene-like protein c-ErbB-3|receptor tyrosine-protein kinase erbB-3|Tyrosine kinase-type cell surface receptor HER3|v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)|ERRP|NISBD2|FERLK|VSCN1|c-erbB-3|MEHD-7945A|RG 7597
规格或纯度
无动物源, 无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥90%(SDS-PAGE&SEC-HPLC), 见COA
生化机理
受体酪氨酸激酶与表皮生长因子家族的配体结合,激活多个信号级联,将细胞外线索转化为适当的细胞反应。已知的配体包括 EGF、TGFA/TGF-α、amphiregulin、epigen/EPGN、BTC/betacellulin、epiregulin/EREG 和 HBEGF/肝素结合 EGF。配体结合会引发受体同源和/或异源二聚化,并在关键的细胞质残基上发生自身磷酸化。磷酸化后的受体招募适配蛋白(如 GRB2),进而激活复杂的下游信号级联。激活至少 4 个主要的下游信号级联,包括 RAS-RAF-MEK-ERK、PI3 激酶-AKT、PLCgamma-PKC 和 STATs 模块。还可能激活 NF-kappa-B 信号级联。还可直接磷酸化 RGS16 等其他蛋白,激活其 GTPase 活性,并可能将 EGF 受体信号转导与 G 蛋白偶联受体信号转导结合起来。还能使 MUC1 磷酸化,增加其与 SRC 和 CTNNB1/beta-catenin 的相互作用。同工酶 2 可作为 EGF 作用的拮抗剂。
HER3:与神经胶质蛋白和 NTAK 结合并被激活。
翻译后:Ser-695 处的磷酸化是部分的,只有在 Thr-693 处磷酸化时才会发生。PRKD1 在 Thr-678 和 Thr-693 处的磷酸化可抑制 EGF 诱导的 MAPK8/JNK1 激活。PTPRJ 的去磷酸化作用可阻止内吞并使受体稳定在质膜上。Tyr-1197 处的自身磷酸化会受到 Arg-1199 处甲基化的刺激,并增强与 PTPN6 的相互作用。Tyr-1092 和/或 Tyr-1110 处的自身磷酸化会招募 STAT3。被 PTPN1 和 PTPN2 去磷酸化。在 EGF 刺激下被单泛素化和多泛素化;这不会影响酪氨酸激酶的活性或信号能力,但可能在溶酶体靶向中发挥作用。多泛素连接主要通过'Lys-63',但也会通过'Lys-48'、'Lys-11'和'Lys-29'连接。OTUD7B 的去泛素化作用可防止降解。被 RNF115 和 RNF126 泛素化。甲基化。PRMT5 在 Arg-1199 处的甲基化刺激了 Tyr-1197 处的磷酸化。
HER3:配体结合会增加酪氨酸残基上的磷酸化,并促进其与磷脂酰肌醇 3-激酶 p85 亚基的结合。
储存与运输
储存缓冲液
Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0
稳定性与储存
在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。
图片
Flow Cytometry: Duligotuzumab (anti-EGFR&HER3) (Ab191943)
Duligotuzumab (anti-EGFR&HER3) (Ab191943) - Flow Cytometry Flow Cytometry analysis of A431 cells labelling EGFR&HER3 (red) with Duligotuzumab (anti-EGFR&HER3) (Ab191943 ) at 1.0 μg/mL for 1 hour at 4°C. Goat Anti-Human IgG (PE) (Ab175838 ) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213 ). Black - Unlabelled control, cells without incubation with primary antibody.
Flow Cytometry: Duligotuzumab (anti-EGFR&HER3) (Ab191943)
Duligotuzumab (anti-EGFR&HER3) (Ab191943) - Flow Cytometry Flow Cytometry analysis of MCF7 cells labelling EGFR&HER3 (red) with Duligotuzumab (anti-EGFR&HER3) (Ab191943 ) at 1.0 μg/mL for 1 hour at 4°C. Goat Anti-Human IgG (PE) (Ab175838 ) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213 ). Black - Unlabelled control, cells without incubation with primary antibody.
ELISA: Duligotuzumab (anti-EGFR&HER3) (Ab191943)
Duligotuzumab (anti-EGFR&HER3) (Ab191943) - ELISA Immobilized Recombinant Human EGFR protein (rp176273 ) at 1.0 μg/mL can bind Duligotuzumab (anti-EGFR&HER3) (Ab191943 ) with the EC₅₀ of 7.264 ng/mL.
ELISA: Duligotuzumab (anti-EGFR&HER3) (Ab191943)
Duligotuzumab (anti-EGFR&HER3) (Ab191943) - ELISA Immobilized Recombinant Human ErbB3/HER3 protein (rp170123 ) at 1.0 μg/mL can bind Duligotuzumab (anti-EGFR&HER3) (Ab191943 ) with the EC₅₀ of 10.56 ng/mL.
SEC: Duligotuzumab (anti-EGFR&HER3) (Ab191943)
Duligotuzumab (anti-EGFR&HER3) (Ab191943) - SEC The purity of Duligotuzumab (anti-EGFR&HER3) (Ab191943 ) is more than 95% verified by HPLC.
高级数据
关联靶点(人)
作用机制
作用机制
Action Type
target ID
Target Name
Target Type
Target Organism
Binding Site Name
参考文献
质检证书(CoA,COO,BSE/TSE 和分析图谱)
技术文档和文章
溶液计算器
相关产品
Goat Anti-Human IgG H&L (HRP)-19553,用于WB,ELISA,IHC各种应用
Mouse Anti-Human IgG Antibody-19553,用于ELISA,CLIA各种应用
Mouse Anti-Human IgG H&L (HRP)-19553,用于ELISA各种应用
Mouse Anti-Human IgM Antibody-19553,用于ELISA各种应用
Human IgG-19554,>95%
Goat Anti-Human IgG Antibody-19553,用于ELISA,CLIA,LFAs,WB and other immunoassay methods各种应用,≥ 95%
Mouse Anti-Human IgA H&L Antibody-19553
Goat Anti-Human IgG (HRP)-19553
Goat Anti-Human IgG (Biotin)-19553
Goat Anti-Human IgG (APC)-19553
Goat Anti-Human IgG (Cy5)-19553
Goat Anti-Human IgG (TRITC)-19553
Goat Anti-Human IgG (PE)-19553
Goat Anti-Human IgG (FITC)-19553
Mouse Anti-Human IgE epsilon chain Antibody-19553
Goat Anti-Human IgG Fc Antibody-19553
Human IgG2-Kappa-19554
Human IgG3-kappa-19554
Izalontamab (anti-EGFR&HER3)-19552
Human IgG1-kappa, anti-Spike RBD-19554
Human IgG4-kappa-19554
Goat Anti-Human IgG (AF647)-19553
Goat Anti-Human IgG (AF405)-19553
Human IgG (FITC)-19554
Human IgG (APC)-19554
Human IgG1(P331S/E430G)-kappa, anti-HEL-19554
Human IgG (PE)-19554
Human IgG1(D265A/N297A)-kappa, anti-HEL-19554
Human IgG1(K409R/E356D/M358L)-kappa, anti-HEL-19554
Human IgG1(P329G/E356D/M358L)-kappa, anti-HEL-19554
Human IgG1(F405L)-kappa, anti-HEL-19554
Human IgG1(N297Q)-kappa, anti-HEL-19554
Human IgG (Biotin)-19554
Human IgG1(N297S)-kappa, anti-HEL-19554
Human IgG1(E233A/L235A)-kappa, anti-HEL-19554
Human IgG1(K214R/N297A)-kappa, anti-HEL-19554
Human IgG1(K214R/L234A/L235A)-kappa, anti-HEL-19554
Human IgG1(N297A/E356D/M358L)-kappa, anti-HEL-19554
Human IgG1(L234F/L235E)-kappa, anti-HEL-19554
Human IgG1(D265A)-kappa, anti-HEL-19554
Human IgG1(K214R/L234F/L235E/P331S)-kappa, anti-HEL-19554
Human IgG1(K214R/E356D/M358L)-kappa, anti-HEL-19554
Human IgG1(L234A/L235A/G237A)-kappa, anti-HEL-19554
Human IgG1(L234A/L235A/F405L)-kappa, anti-HEL-19554
Human IgG1(D270N)-kappa, anti-HEL-19554
Human IgG4(S228P)-kappa, anti-HEL-19554
Human IgG1(N297A)-kappa, anti-HEL-19554
Human IgG4(S228P/L235E/P329G)-kappa, anti-HEL-19554
Human IgG1-lambda1, anti-Spike RBD-19554
Human IgG1-lambda2, anti-Spike RBD-19554
Goat Anti-Human IgG (AF555)-19553
Human IgG1-kappa (AF647), anti-Spike RBD-19554
Human IgG1-kappa (AF405), anti-Spike RBD-19554
Human IgG1-kappa (APC), anti-Spike RBD-19554
Human IgG1-kappa (Biotin), anti-Spike RBD-19554
Human IgG1-kappa (AF700), anti-Spike RBD-19554
Human IgG1-kappa (FITC), anti-Spike RBD-19554
Human IgG1-kappa (AF555), anti-Spike RBD-19554
Centrose patent anti-dysadherin (anti-Dysadherin)-19552
Human IgG (AF647)-19554
Human IgG (AF488)-19554
Human IgG (AF700)-19554
Human IgG (AF405)-19554
Goat Anti-Human IgG (AF488)-19553
Goat Anti-Human IgG Fc (Cy5)-19553
Goat Anti-Human IgG Fc (AF555)-19553
Goat Anti-Human IgG Fc (TRITC)-19553
Goat Anti-Human IgG Fc (AF700)-19553
Goat Anti-Human IgG Fc (AF405)-19553
Goat Anti-Human IgG Fc (Biotin)-19553
Goat Anti-Human IgG Fc (AF647)-19553
Goat Anti-Human IgG Fc (FITC)-19553
Human IgG (AF555)-19554
产品仅提供给经过验证的企业、机构和合格的专业人员用于研发。不适用于人类、动物、诊断或治疗。
Copyright © 2023至今 上海阿拉丁生化科技股份有限公司 SSE:688179 保留所有权利。